National Institutes of Health researchers and their colleagues have identified how resveratrol, a naturally occurring chemical found in red wine and other plant products, may confer its health benefits. The authors present evidence that resveratrol does not directly activate sirtuin 1, a protein associated with aging... … [Read more...]
Exercise In Low Oxygen Environment May Result In Improved Insulin Sensitivity
February 5, 2012 By
Intermittent exercise with and without low oxygen concentrations (or hypoxia) can improve insulin sensitivity in type 2 diabetics, however exercise while under hypoxic conditions provides greater improvements in glycemic control than intermittent exercise alone, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM)... … [Read more...]
Memory Function – Decaffeinated Coffee May Help
February 5, 2012 By
Drinking decaffeinated coffee may improve brain energy metabolism associated with diabetes type 2, according to a study published in Nutritional Neuroscience and carried out by researchers at Mount Sinai School of Medicine. Brain energy metabolism is a dysfunction with a known risk factor for dementia and other neurodegenerative disorders like Alzheimer's disease... … [Read more...]
Occupational health care identifies risk for type 2 diabetes and cardiovascular disease
February 5, 2012 By
Publication year: 2012Source: Primary Care Diabetes, Available online 3 February 2012Katriina Viitasalo, Jaana Lindström, Katri Hemiö, Sampsa Puttonen, Anja Koho, ...AimsTo assess the risk for type 2 diabetes (T2D) and cardiovascular disease (CVD) among employees of a Finnish airline; to study the association of shift work with T2D and CVD risk; and to test the feasibility of risk screening in occupational health care setting.MethodsAltogether 4169 employees were invited for a health check-up and 2312 participated in this study. The check-up included physical examinations, questionnaires on working hours, sleep, and lifestyle, diabetes risk score FINDRISC, and blood tests. Lifestyle counselling was offered for those with increased T2D risk.ResultsAltogether 15% of participants had a high T2D risk (FINDRISC ≥ 15 and/or elevated, but non-diabetic blood glucose), and a further 15% had a moderate T2D risk (FINDRISC 10–14 and normal blood glucose). Of those 60% agreed to attend … [Read more...]
The Trouble with Glucose Testing
February 3, 2012 By
A big new review shows that people who don’t use insulin are wasting their time and money when they test their blood glucose.I agree.And I still recommend that everyone who has diabetes test his or her blood.Do I contradict myself? I don’t think so.The new review comes from the Cochrane Collaboration, the most respected group that reviews scientific studies. Six European experts reviewed a dozen randomized controlled trials of 3259... … [Read more...]
Women, Diabetes, and Cardiovascular Risk
February 3, 2012 By
Is the effect of diabetes on cardiovascular risk greater among women than men? Medscape Diabetes & Endocrinology … [Read more...]
Link Between Insulin Resistance And Brain Health In Elderly
February 3, 2012 By
New research from Uppsala University shows that reduced insulin sensitivity is linked to smaller brain size and deteriorated language skills in seniors. The findings are now published in the scientific journal Diabetes Care. The main hormonal function of insulin is to support the uptake and use of glucose in muscles and fat tissues... … [Read more...]
Metabolic Side Effects Such As Obesity And Diabetes Caused By Antipsychotic Medications
February 3, 2012 By
In 2008, roughly 14.3 million Americans were taking antipsychotics - typically prescribed for bipolar disorder, schizophrenia, or a number of other behavioral disorders - making them among the most prescribed drugs in the U.S... … [Read more...]
Seasonal Changes May Influence The Efficacy Of Vaccination Against Diabetes
February 3, 2012 By
The development of a medicine for patients with type 1 diabetes mellitus, based on autoantigen GAD65, received a setback following crucial clinical phase 3 trials that failed to show significant effects. One possible explanation may be seasonal variations in the immune system, claim those responsible for the study that was published in the New England Journal of Medicine (NEJM)... … [Read more...]
World Diabetes Congress, Dubai—4th–8th December, 2011—Commentary from a UK perspective
February 2, 2012 By
Publication year: 2012Source: Primary Care Diabetes, Available online 31 January 2012Rhys Williams … [Read more...]
